HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by El-Khairy, L. Articles by Vollset, S. E Search for Related Content PubMed PubMed Citation Articles by El-Khairy, L. Articles by Vollset, S. E Agricola Articles by El-Khairy, L. Articles by Vollset, S. E

Lifestyle and cardiovascular disease risk factors as determinants of total cysteine in plasma: the Hordaland Homocysteine Study^1,2,3

¹ From the Division for Medical Statistics, Department of Public Health and Primary Health Care and the Department of Pharmacology, University of Bergen, Norway.

Background: Plasma total homocysteine (tHcy) is a cardiovascular disease risk factor and is related to several components of the established cardiovascular disease risk profile. Cysteine is structurally and metabolically related to homocysteine, but data on its association with cardiovascular disease and cardiovascular disease risk factors are sparse.

Objective: Our objective was to search for the determinants of plasma total cysteine (tCys) and compare them with those of tHcy.

Design: In this cross-sectional study, we studied 7591 healthy men and 8585 healthy women aged 40–67 y with no history of hypertension, diabetes mellitus, coronary heart disease, or cerebrovascular disease.

Results: In the group aged 40–42 y, tCys was significantly higher in men (: 273 µmol/L; 2.5–97.5 percentile: 219–338 µmol/L) than in women (253 µmol/L; 202–317 µmol/L) (P < 0.001). In the group aged 65–67 y, there was no significant sex difference in tCys: men (296 µmol/L; 233–362 µmol/L) and women (296 µmol/L; 234–361 µmol/L). As with tHcy, tCys was positively associated with age, total cholesterol concentration, diastolic blood pressure, and coffee consumption. Body mass index was a strong determinant of tCys but was not related to tHcy. Several factors known to influence tHcy, including smoking status, folate and vitamin intake, heart rate, and physical activity, were not associated or were only weakly associated with tCys.

Conclusion: Plasma tCys is strongly related to several factors that constitute the cardiovascular disease risk profile. This should be an incentive to determine the role of tCys in cardiovascular disease.

Key Words: Plasma total cysteine • homocysteine • body mass index • total cholesterol concentration • coffee consumption • blood pressure • humans • cardiovascular disease risk factors • lifestyle • Hordaland Homocysteine Study • Norway

This article has been cited by other articles:

				C. L. Cresenzi, J.-I. Lee, and M. H. Stipanuk Cysteine Is the Metabolic Signal Responsible for Dietary Regulation of Hepatic Cysteine Dioxygenase and Glutamate Cysteine Ligase in Intact Rats J. Nutr., September 1, 2003; 133(9): 2697 - 2702. [Abstract] [Full Text] [PDF]

				L. El-Khairy, S. E. Vollset, H. Refsum, and P. M. Ueland Plasma Total Cysteine, Mortality, and Cardiovascular Disease Hospitalizations: The Hordaland Homocysteine Study Clin. Chem., June 1, 2003; 49(6): 895 - 900. [Abstract] [Full Text] [PDF]

				M. Schachter, A. Raziel, S. Friedler, D. Strassburger, O. Bern, and R. Ron-El Insulin resistance in patients with polycystic ovary syndrome is associated with elevated plasma homocysteine Hum. Reprod., April 1, 2003; 18(4): 721 - 727. [Abstract] [Full Text] [PDF]

				L. El-Khairy, S. E Vollset, H. Refsum, and P. M Ueland Plasma total cysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine Study Am. J. Clinical Nutrition, February 1, 2003; 77(2): 467 - 472. [Abstract] [Full Text] [PDF]

				L. El-Khairy, S. E. Vollset, H. Refsum, and P. M. Ueland Predictors of Change in Plasma Total Cysteine: Longitudinal Findings from the Hordaland Homocysteine Study Clin. Chem., January 1, 2003; 49(1): 113 - 120. [Abstract] [Full Text] [PDF]

				U. Schwab, A. Torronen, L. Toppinen, G. Alfthan, M. Saarinen, A. Aro, and M. Uusitupa Betaine supplementation decreases plasma homocysteine concentrations but does not affect body weight, body composition, or resting energy expenditure in human subjects Am. J. Clinical Nutrition, November 1, 2002; 76(5): 961 - 967. [Abstract] [Full Text] [PDF]

				P. O'Callaghan, R. Meleady, T. Fitzgerald, I. Graham, and European COMAC group Smoking and plasma homocysteine Eur. Heart J., October 2, 2002; 23(20): 1580 - 1586. [Abstract] [Full Text] [PDF]

				H. Refsum, C. S Yajnik, M. Gadkari, J. Schneede, S. E Vollset, L. Orning, A. B Guttormsen, A. Joglekar, M. G Sayyad, A. Ulvik, et al. Hyperhomocysteinemia and elevated methylmalonic acid indicate a high prevalence of cobalamin deficiency in Asian Indians Am. J. Clinical Nutrition, August 1, 2001; 74(2): 233 - 241. [Abstract] [Full Text] [PDF]

				G. L. Hortin, P. Sullivan, and G. Csako Relationships among Plasma Homocysteine, Cysteine, and Albumin Concentrations: Potential Utility of Assessing the Cysteine/Homocysteine Ratio Clin. Chem., June 1, 2001; 47(6): 1121 - 1124. [Full Text] [PDF]

				L. El-Khairy, P. M. Ueland, H. Refsum, I. M. Graham, and S. E. Vollset Plasma Total Cysteine as a Risk Factor for Vascular Disease : The European Concerted Action Project Circulation, May 29, 2001; 103(21): 2544 - 2549. [Abstract] [Full Text] [PDF]